a nonsignificant trendp = 0.058
A nonsignificant trend of increased RA disease duration was observed in patients with RA + osteoporosis (14 vs. 11 years, p = 0.058) and a higher frequency of anti-MCV antibodies (66.2% vs. 50.6%, p = 0.053).
A nonsignificant trend of increased RA disease duration was observed in patients with RA + osteoporosis (14 vs. 11 years, p = 0.058) and a higher frequency of anti-MCV antibodies (66.2% vs. 50.6%, p = 0.053).